The T cell precursors differentiate into CD4 + and CD8 + T cells during thymic development, a process tightly regulated by several key transcription factors such as RUNX3, ThPOK/cKrox, GATA-3, and Tox (Hernández-Hoyos et al., 2003; Pai et al., 2003; He et al., 2005; Sun et al., 2005; Wang et al., 2008; Aliahmad et al., 2011) . Runx3 is a transcription factor of the RUNX family and binds to the CD4 silencer element, which down-regulates CD4 expression and promotes differentiation to the cytotoxic T cells (CTL) linage (Taniuchi et al., 2002; Woolf et al., 2003) . CTLs play critical roles in protection from viral infection and tumor growth. CD8 + T cells recognize and respond to antigen (Ag) peptides displayed by MHC class I on APCs and target cells, and function to exert cytotoxicity or recruit and activate other immune cells. These CTL effector functions are critically controlled by two T-box transcription factors, T-bet and Eomesodermin (Eomes; Pearce et al., 2003; Eshima et al., 2012) . On the other hand, ThPOK, GATA3, and Tox inhibit the differentiation to CD8 + T cells and induce CD4 + helper T cell development. Naive CD4 + T cells differentiate into various effector T helper (Th) cells such as Th1, Th2, and Th17 cells, which produce IFN-γ, IL-4/IL-5/IL-9/IL-13, and IL-17/IL-22, respectively (O'Shea and Paul, 2010) . Functional differentiation into different Th subsets is regulated by environmental factors, mainly by cytokines; Th1 by IL-12/IFN-γ, Th2 by IL-4, and Th17 by IL-6 and TGFβ. IFN-γ and IL-12 are important for Th1 differentiation, and IFN-γ production is regulated by various transcription factors, such as T-bet, Eomes, Runx3, and STAT4. T-bet in particular is the leading player in Th1 differentiation and regulates not only induction of IFN-γ production but also suppression of the expression of GATA-3, the master regulator of Th2 differentiation. Although the differentiation of these CD4 + Th subsets has been well defined, little is known about regulation of the development of the CD4 + subset with cytotoxic function, the CD4 + CTL. Cytotoxic CD4 + T cells (CD4 + CTL) were identified as T cells that have the ability to acquire cytotoxic activity and directly kill infected, transformed, or allogeneic MHC class (Wagner et al., 1977; Feighery and Stastny, 1979) and mice (Lukacher et al., 1985; Maimone et al., 1986) , and CD4 + CTL have also been identified among the peripheral blood mononuclear cells (PBMCs) of humans seropositive after chronic viral infections such as human cytomegalovirus (HCMV; van Leeuwen et al., 2004; Zaunders et al., 2004) , HIV-1 (Appay et al., 2002; Zaunders et al., 2004) , and hepatitis virus (Aslan et al., 2006) , as well as in mice infected by lymphocytic choriomeningitis virus (LCMV; Jellison et al., 2005) or γ-herpes virus (Stuller and Flaño, 2009) . It has been suggested that CD4 + CTL could have a potential therapeutic role for antitumor immunity (Quezada et al., 2010; Xie et al., 2010) .
Naive T cells differentiate into various effector T cells, including CD4 + helper T cell subsets and CD8 + cytotoxic T cells (CTL). Although cytotoxic CD4
We have previously identified MHC class I-restricted T cell-associated molecule (CRT AM) as an Ig domain-containing and activation-induced surface receptor predominantly expressed on activated CD8 + T cells and NK/NKT cells, and cell adhesion molecule 1 (CADM1)/Necl2/TSLC1 as its ligand (Kennedy et al., 2000; Kuramochi et al., 2001; Arase et al., 2005; Boles et al., 2005; Galibert et al., 2005) . The CRT AM-CADM1 binding results from a heterotypic interaction between different cell types. CRT AM is transiently expressed in the early phase of T cell activation, and CRT AM 
RES ULTS CRT AM expression on a small fraction of CD4
+ T cells We previously reported that almost all CD8 + T cells transiently express CRT AM at the early stage of T cell activation. Yeh et al. (2008) first reported that a small fraction of activated CD4 + T cells also express CRT AM and suggested that the CRT AM-expressing cells might be a distinct T cell subpopulation. We now confirm that CRT AM is expressed on the surface of ∼2-5% of splenic CD4 + T cells after TCR stimulation (Fig. 1 A) . To characterize this unique population of CRT AM-expressing CD4 + T cells, CRT AM + and CRT AM − cells were sorted after stimulation, and the production of various cytokines was analyzed. The CRT AM + T cells produced high levels of effector cytokines, such as IFN-γ, IL-17, and IL-22, but not IL-4 (Fig. 1 B) . We assumed that the CRT AM + population contains effector-memory T cells that produce high levels of effector cytokines. (Fig. 1 C) . Interestingly, CRT AM + cells were detected in each subset, although naive cells generated fewer than memory cells. As expected, CRT AM + effector memory CD4 + T cells produce much higher amounts of IFN-γ and IL-17a than CRT AM − cells (Fig. 1 D) , and restimulation of CRT AM + cells induced higher levels of CRT AM expression (Fig. 1 E) . In contrast, only a small percentage of CRT AM − T cells become CRT AM + cells after stimulation. These data suggest that a majority of CRT AM-expressing CD4 + T cells are memory-type T cells that produce high levels of cytokines. However, we noticed that a small fraction of naive CD4 + T cells also express CRT AM upon stimulation ( Fig. 1 C) . We found that the CRT AM + activated naive T cells produce high amount of IFN-γ but not other effector cytokines (Fig. 1 D) . Because this population is different from the effector memory population, this observation indicates that activated naive CD4 + T cells already contain some T cells producing IFN-γ immediately after stimulation. Next, we tested whether the expression of CRT AM on activated naive CD4 + T cells is constant or flexibly changed by the interaction with different APC populations (Fig. 1 F) . Naive OT-II Tg CD4 + T cells were stimulated by peptide-pulsed various APCs, including B cells, DCs, and macrophages. B cells and macrophages induced CRT AM in a similar level to those stimulated by anti-CD3 Ab or P+I. In contrast, more than fourfold of CRT AM-expressing cells were induced by stimulation with DCs. These data indicate that CRT AM expression is flexibly induced by environmental situation, most efficiently upon DC stimulation.
CRT AM + CD4 + T cells have characteristics of both CD4
+ and CD8 + T cells After the observation that CRT AM + naive CD4 + T cells are high producers of IFN-γ, we analyzed the expression of transcription factors related to IFN-γ production such as RUNX3, T-bet, and Eomes (Fig. 2 C) . The expression of T-bet and Runx3 was comparable to that in CRT AM −
CD4
+ T cells but, interestingly, Eomes expression was clearly up-regulated in the CRT AM + CD4 + T cells. Considering that Eomes is predominantly expressed in CD8 + T cells and induces IFN-γ production, and that T-bet directly activates IFN-γ transcription and is considered to be the master regulator of Th1 differentiation (Szabo et al., 2000 (Szabo et al., , 2003 Pearce et al., 2003; Glimcher et al., 2004) the cell surface. CD8α mRNA expression was not a result of contaminating CD8 + T cells because CD8 + T cells were extensively eliminated during the purification of naive CD4 + T cells. Indeed, we could not detect the cell surface expression of CD8α even 6 d after stimulation (Fig. 2 D) . In contrast, the expression of Eomes, IFN-γ, and gzmB were slightly but significantly increased at the protein levels in CRT AM + CD4 + T cells, whereas CRT AM + T cells tend to express less T-bet (Fig. 2 E) . From these data, we confirmed that CTL-related genes are up-regulated in CRT AM + CD4 + T cells at both mRNA and protein levels, except for CD8α expression. + T cells differentiated to IFN-γ-producing cells. These cells are not typical Th1 cells because they express high levels of CTL-related genes but not T-bet (Fig. 3 B + T cells. CRT AM + and CRT AM − CD4 + T cells were prepared similarly as in C were subjected to intracellular staining, and were analyzed by flow cytometry using specific Abs. Microarray analysis was performed once with three mice from each sample. The numbers indicate the percentages of positive cells expressing each gene. Data (C-E) are representative of at least two independent experiments. Error bars are SD. ***, P < 0.001, Student's t test.
CRT
T cells. Alternatively, this could be attributed to experimental conditions. Because CRT AM is expressed only upon stimulation, CRT AM + CD4 + T cells were sorted after stimulation. Thereafter, the sorted T cells were returned to the culture for restimulation. Such slightly modified stimulation/culture condition may have reduced population producing IFN-γ. We also confirmed the expression of the transcription factors that are critical for each Th subset differentiation under the each skewing conditions (Fig. 3 C) . Under Th1-skewing condition, both CRT AM + and CRT AM − populations showed high levels of IFN-γ, but T-bet expression was not increased in CRT AM + CD4 + T cells. However, other lineage specification transcription factors clearly up-regulated under the relevant skewing conditions. Interestingly, CTL-related genes such as Eomes, gzmB, and perforin were still increased in CRT AM + CD4 + T cells under the skewing conditions for Th0, Th1, and Th2. Next, we analyzed the CXCR3 expression level as a marker of the Th1 cells (Fig. 3 D) . In all situations, the CXCR3 expression was clearly up-regulated in CRT AM + CD4
+ T cells. These data suggest that CRT AM + CD4 + T cells seem to be able to differentiate into each Th subsets; however, they are atypical Th subsets with remaining unique features of CTL. Whereas these activated naive CRT AM + T cells expressed Eomes, IFN-γ, and gzmB, but not perforin (Fig. 2 C) , the CRT AM + effector T cells clearly showed elevated expression of perforin after 6 d of culture in the presence of IL-2. These results suggest that CRT AM + CD4 + T cells may also have cytotoxic function. This possibility was indeed demonstrated in a retargeting cytotoxicity assay (Fig. 3 E + T cells already express IFN-γ and Eomes before differentiation. Because it is well known that Eomes activates IFN-γ transcription, we examined the possibility that CRT AM expression is also induced in naive T cells by Eomes. For this purpose, the Eomes-IRES-eGFP genes were introduced into activated CD4 + T cells and the surface expression of CRT AM was analyzed after restimulation (Fig. 4 A) . However, no CRT AM expression was observed on the surface of Eomes-introduced T cells. We could not detect CRT AM mRNA, even though IFN-γ expression was clearly enhanced by the transfection of Eomes (Fig. 4 B) . We further analyzed CRT AM expression by using Eomes-deficient CD4 + T cells (Fig. 4 C) . The same level of CRT AM expression was observed on the Eomes-deficient T cells after stimulation. These results indicate that CRT AM expression is not regulated by Eomes.
CRT AM induces Eomes, IFN-γ production, and CTL function
To analyze the function of CRT AM, we intended to prepare mice whose T cells all expressed CRT AM. For this purpose, we generated CRT AM knock-in (KI) transgenic (Tg) mice. A full-length CRT AM (CR-FL) cDNA attached to IRES-GFP was located downstream of a LoxP-Stop-LoxP cassette under the control of the CAG promoter and integrated into the Rosa26 locus, and the Tg mice were crossed with Lck-cre Tg mice (Fig. 5 A) . In the Tg mouse, even though all T cells constitutively expressed GFP, the constitutive expression of CRT AM on the cell surface was not detected, but all CD4 + T cells immediately expressed cell surface CRT AM upon stimulation (Fig. 5 B) . These results suggest that CRT AM expression is also regulated at the translational or posttranslational level. To distinguish these two possibilities, naive T cells from the Tg mice were treated with MG132, a potent proteasome inhibitor, and there was clear induction of surface expression of CRT AM without stimulation (Fig. 5 C) . These results indicate that CRT AM expression is tightly regulated both transcriptionally and posttranslationally.
In the CRT AM-FL Tg mouse, CD44 hi effector memory cells were dramatically increased both in CD4 + and CD8 + T cell compartments, and the production of effector cytokines was clearly enhanced (Fig. 5 D and not depicted) , confirming that CRT AM expression induces further maturation of effector memory cells and the production of effector cytokines. However, naive T cells in the Tg mice showed normal proliferation and IL-2 production upon stimulation (Fig. 5 E) . The production of IFN-γ was clearly elevated, though at a low level, upon activation (Fig. 5, E and G) . Interestingly, although IFN-γ production was enhanced, the expression of CTL-related genes was not induced (Fig. 5 G) . These results suggest that naive CRT AM Tg CD4 + T cells do not yet have CTL competence at the early stage of T cell activation.
Next, we analyzed the ability of the Tg CD4 + T cells to differentiate into Th1, Th2, and Th17 cells (Fig. 6 A and not depicted). They could differentiate into all Th subsets under optimal conditions after 5-6 d of culture. We also noted that a high proportion of the Tg T cells differentiate into IFN-γ-producing cells under nonskewing conditions, similar to the situation in CRT AM + WT T cells. These IFN-γ-producing T cells also express high levels of Eomes, gzmB, and perforin (Fig. 6 B) , and they acquired cytotoxic function against target (Fig. 6 C) . These CTL-related proteins were clearly induced after their stimulation-induced differentiation, whereas their expression was not enhanced in activated naive T cells (Fig. 5 G) . These data indicate that CRT AM expression resulted in the induction of the expression of IFN-γ, CTL-related genes, and the acquisition of cytotoxic function.
We then analyzed whether CRT AM-mediated signaling was involved in the CD4 + CTL differentiation by analyzing KI-Tg mice expressing a truncated form of CRT AM lacking its cytoplasmic domain (tail-less mutant; CR-TL; Fig. 5 A) . In this mouse, CD44
hi effector-memory T cells increased, similar to the case in CR-FL Tg (Fig. 5 F, left) . However, unlike CR-FL Tg, the production of effector cytokines such as IFN-γ and IL-17 was not enhanced at all (Fig. 5 F, right) . Even though these T cells could differentiate into each Th subset under the appropriate differentiation conditions (Fig. 6 A and not depicted), unlike CR-FL T cells, these CR-TL T cells did not become IFN-γ-producing cells under nonskewed conditions and also did not develop cytotoxic functions (Fig. 6 , B and C). Collectively, these results indicate that the cytoplasmic region of CRT AM is critical for inducing intracellular signaling for IFN-γ production and differentiation of CD4 + CTLs, whereas the extracellular domain is involved in maturation of effector memory T cells. (Fig. 7 , A and D), indicating that CRT AM + CD4 + T cells have a tendency of traffic to mucosal tissues. We also examined the possibility that CRT AM + T cells could be observed in the inflammatory sites upon infection. It was recently reported that CD4 + T cells that are activated by influenza virus infection could acquire CTL activity and contribute to protection against influenza virus infection (Brown et al., 2012) . Thus, we analyzed the CRT AM expression level on CD4 + T cells that reside in the lung after influenza virus infection (Fig. 7 A) . As expected, a higher percentage of CRT AM + CD4 + T cells were detected in the virus-infected lung compared with noninfected control. CRT AM + CD4 + T cells exhibited high expression of Eomes and gzmB, as well as IFN-γ production (Fig. 7 B) . More importantly, these CD4 + T cells from the lung exhibited influenza-specific cytotoxicity, whereas CD4 + T cells from virus-infected CRT AM-KO mice showed very diminished killing activity (Fig. 7 C) . These data indicate that after the influenza virus infection, high proportion of CRT AM + T cells were detected in the infected inflammatory sites, and they develop into Ag-specific CD4 + CTL. In addition to the lung infection, we found that iLP contains a relatively high proportion of CRT AM + CD4 + T cells. This is consistent with the idea that CRT AM + T cells traffic into inflammatory sites. Because the CRT AM ligand CADM1 is widely expressed in the gut (not depicted), we next used CADM1-KO mice to address the question of whether increasing the percentage of CRT AM + T cells is dependent on the CRT AM-CADM1 interaction. The number of CRT AM + cells in iLP was comparable between CADM1-KO and WT mice (Fig. 7 E, left) , indicating that the CRT AM-CADM1 itself is not involved in the induction of CRT AM expression in iLP. However, we found that the CRT AM-CADM1 interaction is involved in effector-memory differentiation (Fig. 7 E, right) . In CADM1-KO mice, effector-memory T cells are slightly decreased in spleen. Furthermore, even though almost all iLP CD4 + T cells showed effector-memory phenotype in CADM-1 heterozygous mouse, naive cells were 10 times higher in CADM1-KO mouse (Fig. 7 E) . These results are consistent with those of CRT AM Tg in Fig. 5 , and support the idea that CRT AM-CADM1 interaction is involved in maturation of effector memory T cells, but not in the development of CD4 + CTL.
CRT AM + T cells contribute to induction of intestinal colitis
To clarify the in vivo function of CRT AM + CD4 + T cells, we analyzed their role in the induction of colitis using a T cell-mediated colitis model. Purified naive CD4 + CD45RB hi CD25 − T cells were transferred into RAG-deficient mice to induce colitis. After the induction of colitis, infiltrating cells were isolated from inflamed colon lamina propria (cLP) and epithelia (cIEL), and the percentage of CRT AM + CD4 + T cells was quantified (Fig. 7 D) . Considering that CRT AM + CD4 + T cells are present only at 1-4% in the spleen and LN, interestingly, >40% of CD4 + T cells in cLP and 67% of cIEL in the inflamed area expressed CRT AM, indicating that CRT AM + CD4 + T cells are enriched in colonic inflammatory sites. To clarify the contribution of CRT AM expression, we compared colitis symptoms induced by CRT AM −/− T cells (Fig. 7 F) . Analysis of colitis-induced body weight loss clearly showed that CRT AM −/− CD4 + T cells almost failed to induce colitis. These data indicate that CRT AM + CD4 + T cells may be involved in the efficient induction of inflammation and also in the defense against pathogens in the gut.
Our data clearly demonstrated that CRT AM + CD4 + T cells are able to produce high level of IFN-γ (Fig. 2 C) , and CRT AM expression efficiently induce differentiation to IFN-γ and IL-17-secreting cells in vivo (Fig. 5 D) . These cytokines are known to play key roles in the induction of colitis in this model (Powrie et al., 1994; Ito and Fathman, 1997; O'Connor et al., 2009; Sujino et al., 2011) . In addition, our data suggested the possibility that CD4 + CTL activity is also involved in inflammation in the gut. This was supported by the analysis of gzmB −/− T cells (Fig. 7 G) . Whereas the naive T cells from gzmB-KO mice could induce colitis, the induction of body weight loss was much slower by gzmB −/− T cells although they eventually induce colitis. When compared with CRT AM −/− T cells, the induction of colitis by the gzmB −/− T cells appeared more severe than induction by CRT AM −/− T cells (Fig. 7 , F and G), suggesting that CD4 + CTL activity may also contribute to the induction of colitis in this model, together with inflammatory cytokines. These results strongly suggest that CRT AM + CD4 + T cells play critical roles in inflammationthrough cytokine production and CTL function.
DIS CUSSI ON
We show here that a small fraction of activated CD4 + T cells expressing CRT AM contain the immediate precursor of CD4 + cytotoxic T cells and that CRT AM expression induces the process of differentiation into CD4 + CTL. CD4 + CTLs mediate their killing function by the directed exocytosis of cytotoxic granules toward target cells, such as CD8 + CTL, to induce apoptosis. Degranulation of the perforin and Granzyme B-containing granules is required for the killing of target cells (Marshall and Swain, 2011) , and the cytotoxic activity is further enhanced under nonskewed conditions in the presence of IL-2 (Brown et al., 2009) . Together with these studies, our data suggest that the CRT AM + CD4 + T cells with cytotoxic function are identical to the previously described CD4 + CTL. Our findings clearly demonstrated that the CD4 + CTL precursor already exists at the early stage of T cell activation and that precursor cells express CRT AM. CRT AM expression is also regulated by cellular interaction, and it is particularly efficiently induced by the interaction with DC. After T cell activation, CRT AM-mediated signaling induces the expression of CTL-related genes, and the CRT AM + T cells differentiate into CD4 + CTL in the presence of IL-2. We confirmed that this system is also functioning in human T cells; human T cells contain a small fraction of CRT AM + T cells, which generate CD4 + CTL similar to mouse T cells. This observation was also confirmed by CRT AM knock-in (KI) Tg mice. T cells from the full-length CRT AM-FL, but not from the tail-less mutant CRT AM-TL Tg mice, differentiated into CD4 + CTL in vivo. Therefore, CD4 + CTL development is dependent on CRT AM-induced signals, which are mediated through the intracellular domain. The intracellular domain of CRT AM contains a PDZ-binding motif at the C terminus; one family of PDZ-containing protein, the Discs Large (DLG), selects this sequence (Kornau et al., 1995; Songyang et al., 1997) . It has been shown that Scrib, one member of this protein family, binds to CRT AM and regulates T cell polarity and cytokine production, and that knockdown of Scrib results in the reduction of IFN-γ production (Yeh et al., 2008) . Together with the aforementioned findings, our results suggest that the differentiation of CD4 + CTL is also regulated by CRT AM-Scrib -mediated signaling.
Although CRT AM is critical for the development of CD4 + CTL, the requirement for the CRT AM ligand CADM1 is complex. Although CADM1 is highly expressed on epithelial cells and CD8 + dendritic cells (Shingai et al., 2003; Galibert et al., 2005) , because there were no CADM1-expressing cells in our in vitro experiments, CD4 + CTL can be differentiated in the absence of the interaction between CRT AM and CADM1. However, because of several reports suggesting weak expression of CADM1 by T cells (Yeh et al., 2008; Takeuchi et al., 2009; Kim et al., However, our results suggested that the CRT AM-CADM1 interaction is involved in the expansion of memory phenotype cells in vivo, because the tailless CRT AM-TL Tg mice increases memory-type cells to the level similar to WT mice even in the absence of the CRT AM-mediated signals. In this case, similar to CRT AM-mediated CD8 + T cell development, as previously shown (Takeuchi et al., 2009) , it is speculated that the CRT AM-CADM1 interaction is important to enhance the retention and maturation of CD4 + T cells to effector memory cells within LNs.
We also demonstrated that CRT AM + CD4 + T cells have in vivo function in the colitis induction model. CRT AM + CD4 + T cells were clearly increased at the inflammation sites. This is consistent with a recent study indicating that CRT AM + CD4 + T cells accumulate in the intestine (Cortez et al., 2014) , and our data strongly suggests that CRT AM + CD4 + T cells function at the inflamed site to induce colitis through both CTL activity and cytokine production. When CRT AM −/− CD4 + T cells were transferred, inflammation became milder than observed with WT cells, suggesting that CRT AM-mediated signals are important for differentiation into CD4 + CTL and secretion of inflammatory cytokines. In our influenza virus infection model, CRT AM + T cells accumulated in the infection sites, and developed into CD4 + CTL mediating virus-specific cytotoxicity. These results support previous studies that CD4 + CTL can function as a compensatory mechanism when CD8 + CTL activity is impaired in the case as chronic viral infections (Stuller and Flaño, 2009; Zhou and McElhaney, 2011) . Because CD8 + T cells are absent in the colitis model, CD4 + CTL may predominantly function similar to the chronic infection case. Because CD4 + CTL are restricted by MHC class II, class II expression is critical for CD4 + CTL function. Whereas MHC class II is normally expressed only on APCs, such as DCs, macrophages, and B cells, the treatment with IFN-γ or radiation induces class II expression on epithelial or tumor cells (Quezada et al., 2010; Xie et al., 2010; Thibodeau et al., 2012; Thelemann et al., 2014) . Because IFN-γ is an essential factor for the induction of inflammation in the colitis model, it is likely that secreted IFN-γ induces class II expression on intestinal epithelia, which could accelerate CD4 + CTL activity. The observation that CRT AM −/− CD4 + T cells failed to efficiently induce inflammation may reflect the likely multiple functions of CRT AM at several points of colitis induction, which may synergistically induce exacerbation of symptoms. First, CRT AM-mediated induction of CD4 + CTL and their production of inflammatory cytokines would directly induce inflammation. Second, based on the finding that the number of T cells in the gut was clearly decreased during the colitis when CRT AM −/− T cells were transferred, CRT AM likely enhances the recruitment of T cells in the gut (Cortez et al., 2014) . Third, based on our previous observation that CRT AM −/− CD8 + T cells cannot proliferate well within the draining LN, CRT AM appears to play a role in retention and functional maturation of CD4 + T cells in LNs, similar to CD8 + T cells (Takeuchi et al., 2009) .
Recently, two papers reported a unique population of T cells that express CD4 + CD8α + and reside in the gut Reis et al., 2013) . This population has CTL function and can be generated from CD4 + CD8 − peripheral T cells by treatment with TGFβ and retinoic acid (RA), which induce up-regulation of RUNX3 and down-regulation of ThPOK expression. We also confirmed the presence of CD4 + CD8α + T cells in the colitis induction model. Interestingly, all CD4 + CD8α + T cells express CRT AM after stimulation. However, >80% of CRT AM-expressing cells in the gut lamina propria were CD4 + CD8α − T cells (not depicted), indicating that some of the CRT AM-expressing cells are CD4 + CD8α + T cells. Furthermore, in the case of splenic CRT AM + CD4 + T cells, CD8α expression was not observed on the cell surface and the expression of ThPOK and RUNX3 were almost the same as in CRT AM − CD4 + T cells (Fig. 2, C and D) . Nevertheless, because CTL function was clearly observed after cultivation (Fig. 3 E) , these data indicate that CD4 + CTL are not equivalent to the CD8α-expressing T cells.
Because the perforin expression was induced only after incubation, CRT AM + CD4 + T cells do not have CTL function initially but differentiate into CTL after incubation. These (Cortez et al., 2014) , suggesting that the maturation from CD4 + CD8 − CTL in LNs into CD4 + CD8 + CTL, as well as their maintenance in the gut, is induced through the CRT AM-CADM1 interaction. This speculation suggests that the CTL have already determined the fate to differentiate into CD4 + CD8α + cells before down-regulation of ThPOK. Therefore, CRT AM expression defines the lineage of CD4 + CTL after stimulation.
Consistently, the expression of CTL-related genes is induced in the CRT AM + CD4 + T cells, and the cells acquire characteristics similar to CD8 + CTL and the CTL activity. Thus, CRT AM expression is critical for differentiation of the CD4 + T cells into the CTL linage, and CRT AM is thus a useful and functional marker to define CTL-inducible cells. These characteristics might be able to control CD4 + CTL functions and should be applicable for therapeutic aims. CD4 + CTLs enriched in infectious/inflammatory sites may function for protective immunity, especially in chronic virus infection or antitumor responses, and the CD4 + CTLs can now be generated and expanded using CRT AM as a defined marker. Alternatively, blockade of CRT AM may become a target for the treatment of inflammatory diseases. Quantitative PCR. Total RNA was prepared from sorted cells by RNeasy Mini kit (QIA GEN) and treated with DNase (Nippongene). cDNA was synthesized using SuperScript II reverse transcription (Invitrogen). qPCR was performed with the Fast Syber Green Master Mix (Applied Biosystems). Data were collected and calculated by using the StepOnePlus real-time PCR system (Applied Biosystems).
(naive) T cells were isolated from spleens using a FAC SAria cell sorter (BD). For Th0 cells, cells were stimulated with plate-bound anti-CD3ε (2C11; 10 µg/ml) and anti-CD28 (PV-1; 1 µg/ml) Abs in the presence of the indicated ligands. For Th1 cells, cells were cultured in the presence of IL-12 (10 ng/ml) and anti-IL-4 Abs (10 ng/ml). For Th2 cells, cells were similarly cultured in the presence of IL-4 (10 ng/ml) and anti-IFN-γ (10 ng/ml). For Th17, IL-6 (20 ng/ml), TGFβ (10 ng/ml), anti-IL-4 Abs (10 ng/ml), and anti-IFN-γ Abs (10 ng/ml).
Intracellular cytokine staining. CD4 + T cells were restimulated with immobilized anti-CD3ε and anti-CD28 for 6 h in the presence of 2 µM monensin (Sigma-Aldrich). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100. After blocking with 3% BSA-PBS, cells were stained with antibodies to each cytokine. Flow cytometric analysis was performed on a FAC SCalibur (BD) and data were analyzed with Cell Quest (BD).
Isolation and analysis of human T cells. PBMCs were isolated from healthy donors by centrifugation over Ficoll density gradient. CD4 + T cells were isolated by anti-human CD4 MACS beads (Miltenyi Biotec) and were stimulated by 10 µg/ml of anti-human CD3 antibody (OKT3) for 14 h. After stimulation, T cells were stained with anti-human CRT AM mAb (Cr24.1; BioLegend), and CRT AM + and CRT AM − cells were sorted by FAC SAria and incubated with 2,000 U/ml of human IL-2 (Ajinomoto) for 5 d. These experiments were performed in compliance with the institutional guidelines of the Tokyo University of Science (Tokyo, Japan), and all subjects provided informed consent as approved by the ethical committee. Healthy volunteers were recruited after obtaining informed consent.
Influenza virus infection.
Influenza A virus (H1N1) A/PR8 was obtained from ATCC. Infection was performed by intranasal injection of virus suspension in PBS with the sublethal dose, which was defined as causing 20% weight loss (200-400 pfu). CD4 + T cells were purified from the lung at 6 d after infection by using gentleMACS (Miltenyi Biotec). For influenza virus-specific killing assay, NP peptide (NP 264-279; LIL RGSVA HKSCL PAC; Gao et al., 1989 ) was used to pulse to LPS-activated B cells from C57BL/6 mice as the target cells. In vitro cytotoxicity assay. For retargeting cytotoxic assay, naive CD4 + T cells were stimulated by plate-coated anti-CD3ε and anti-CD28 for 14 h, and then sorted into CRT AM + and CRT AM − cells. Sorted T cells were further incubated for 5 d in the presence of IL-2 and were differentiated into effector cells. CFSE-labeled A20 cells (target cells: low intensity) and Jurkat cells (internal control: high intensity) were mixed at a one-to-one ratio and coincubated with 10 5 target cells for 4 h in the presence of anti-CD3ε antibody (10 µg/ml). After the incubation, living target cells were quantified by flow cytometry. For influenza-specific cytotoxic assay, CD4 + T cells were isolated from the lungs of mice that were infected with influenza virus using autoMACS. Wild-type and CRT AM −/− T cells were labeled with different concentrations of CMT PX, and graded numbers of T cells were mixed with the target B cells which had been activated by LPS for 12 h and pulsed with Influenza virus NP peptide 264-279 (LIL RGSVA HKSCL PAC) for 6 h (Gao et al., 1989) . The mixture was centrifuged and incubated for 6 h, and the cytotoxicity was analyzed by flow cytometry using FAC SCanto (BD) after staining with PI.
Gene expression profiling. Naive CD4 + and CD8 + T cells (CD25 − CD62L hi CD44 lo ) were purified from spleen and LNs by flow cytometry. Cells were stimulated by plate-coated anti-CD3ε (10 µg/ml) and anti-CD28 (1 µg/ml) antibody for 14 h. The activated cells were stained by anti-CRT AM antibody and resorted into CRT AM + and CRT AM − cells. RNA was isolated, labeled, and hybridized to a Mouse Genome 430 2.0 array (Affymetrix). Expression values for each probe set were calculated using the GC-RMA method in the GeneSpring GX 7.3 software package (Agilent Technologies).
The microarray data are available in the Institute of Physical and Chemical Research database (http ://refdic .rcai .riken .jp /welcome .cgi). Sample numbers are RSM14569, RSM14571, and RSM14572.
